Immunocore Holdings plc American Depositary Shares (IMCR) Stock Price

IMCRStock

$36.62+13.59%52W

Market Cap$1.89B

P/E—

PEG Ratio—

Div yield—

Beta0.80

IMCR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-3.20%

Price vs S&P 500 (4W)11.38%

VGM Score59.52

P/CF (Annual)62.82x

Book Value / Share (Quarterly)$8.15

P/TBV (Annual)9.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)40.67%

Cash Flow / Share (Quarterly)$-0.70

Price vs S&P 500 (YTD)-7.32%

Gross Margin (TTM)98.90%

Net Profit Margin (TTM)-4.20%

EPS (TTM)$-0.37

10-Day Avg Trading Volume0.39M

EPS Excl Extra (TTM)$-0.37

Revenue Growth (5Y)67.77%

EPS (Annual)$-0.71

ROI (Annual)-4.59%

Gross Margin (Annual)98.73%

Net Profit Margin (5Y Avg)-114.48%

Cash / Share (Quarterly)$17.10

Revenue Growth QoQ (YoY)18.34%

ROA (Last FY)-3.33%

Revenue Growth TTM (YoY)20.95%

EBITD / Share (TTM)$-0.37

ROE (5Y Avg)-25.99%

Operating Margin (TTM)-5.24%

Cash Flow / Share (Annual)$-0.30

P/B Ratio4.19x

P/B Ratio (Quarterly)3.85x

Net Income / Employee (Annual)$-67,800

EV / Revenue (TTM)3.88x

Net Interest Coverage (TTM)-176.01x

ROA (TTM)-1.66%

EPS Growth QoQ (YoY)153.36%

EPS Incl Extra (Annual)$-0.71

Current Ratio (Annual)4.04x

Quick Ratio (Quarterly)4.15x

3-Month Avg Trading Volume0.48M

52-Week Price Return13.59%

EV / Free Cash Flow (Annual)73.32x

Revenue / Employee (TTM)$822,100

Tangible BV / Share (Quarterly)$169.97

P/S Ratio (Annual)4.40x

Asset Turnover (Annual)0.37x

52-Week High$40.71

Operating Margin (5Y Avg)-119.14%

EPS Excl Extra (Annual)$-0.71

CapEx CAGR (5Y)7.17%

26-Week Price Return8.73%

Quick Ratio (Annual)3.94x

13-Week Price Return26.41%

Total Debt / Equity (Annual)1.03x

Current Ratio (Quarterly)4.47x

Enterprise Value$1.67B

Revenue / Share Growth (5Y)62.02%

Asset Turnover (TTM)0.40x

Revenue / Employee (Annual)$763,400

Inventory Turnover (Annual)0.83x

Pretax Margin (Annual)-4.77%

Cash / Share (Annual)$17.05

3-Month Return Std Dev32.09%

Net Income / Employee (TTM)$-34,500

ROE (Last FY)-9.32%

Net Interest Coverage (Annual)-12.65x

EPS Basic Excl Extra (Annual)$-0.71

P/FCF (TTM)116.27x

Receivables Turnover (TTM)5.22x

EV / Free Cash Flow (TTM)519.48x

Total Debt / Equity (Quarterly)0.94x

EPS Incl Extra (TTM)$-0.37

Receivables Turnover (Annual)5.84x

ROI (TTM)-2.28%

P/S Ratio (TTM)4.09x

Pretax Margin (5Y Avg)-121.73%

Revenue / Share (Annual)$7.95

Tangible BV / Share (Annual)$5.79

Forward P/E778.99x

Price vs S&P 500 (52W)-4.97%

Year-to-Date Return5.50%

5-Day Price Return0.03%

EPS Normalized (Annual)$-0.71

ROA (5Y Avg)-14.14%

Net Profit Margin (Annual)-8.88%

Month-to-Date Return8.31%

Cash Flow / Share (TTM)$-1.24

EBITD / Share (Annual)$-0.84

Operating Margin (Annual)-11.34%

LT Debt / Equity (Annual)1.03x

P/CF (TTM)204.86x

ROI (5Y Avg)-18.48%

LT Debt / Equity (Quarterly)0.94x

EPS Basic Excl Extra (TTM)$-0.37

P/TBV (Quarterly)6.45x

P/B Ratio (Annual)4.52x

Inventory Turnover (TTM)0.72x

Pretax Margin (TTM)-0.63%

Book Value / Share (Annual)$7.52

Price vs S&P 500 (13W)24.45%

Beta0.80x

P/FCF (Annual)84.29x

Revenue / Share (TTM)$8.45

ROE (TTM)-4.54%

52-Week Low$27.55

vGradeD

gGradeB

mGradeB

vgmGradeC

IMCR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.02	-$0.02	-195.65%(-$0.04)
Q1 2026	May 6, 2026	-$0.26	$0.25	+196.46%(+$0.51)
Q4 2025	Feb 25, 2026	-$0.20	-$0.60	-195.96%(-$0.40)
Q3 2025	Nov 6, 2025	-$0.24	$0.00	+100.00%(+$0.24)
Q2 2025	Aug 7, 2025	-$0.21	-$0.20	+3.13%(+$0.01)

IMCR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

4.05

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$36.62
AMGNAmgen Inc	C	C	B	$432.42
GILDGilead Sciences Inc	C	B	B	$145.68
ARGXargenx SE American Depositary Shares	D	A	B	$1023.21
MRNAModerna, Inc. Common Stock	D	C	A	$137.99
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$207.88
BIIBBiogen Inc. Common Stock	C	D	B	$218.50
BNTXBioNTech SE American Depositary Share	C	C	C	$102.08
NBIXNeurocrine Biosciences Inc	C	B	C	$154.06
EXELExelixis Inc	C	B	B	$54.45
HALOHalozyme Therapeutics, Inc.	C	B	B	$105.35
TECHBio-Techne Corp.	D	C	B	$72.35
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$351.46
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.97
RGENRepligen Corp	D	C	B	$176.27
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$118.15
PCVXVaxcyte, Inc. Common Stock	—	—	B	$59.84
QGENQIAGEN N.V.	C	C	B	$43.11
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$141.38
IBRXImmunityBio, Inc. Common Stock	F	A	B	$8.05
IMVTImmunovant, Inc. Common Stock	—	—	B	$41.20
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$57.80
CGONCG Oncology, Inc. Common stock	F	A	B	$74.34
CRSPCRISPR Therapeutics AG	D	B	C	$57.72
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	$18.77
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$25.19
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.00
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.01
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.76
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$29.32
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.82
KODKodiak Sciences Inc Common Stock	—	—	B	$37.72
MESOMesoblast Limited American Depositary Shares	D	B	B	$17.44
VCELVericel Corporation	D	B	B	$40.95
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$44.84
ADMAADMA Biologics, Inc.	C	C	C	$9.34
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$5.77
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.83
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	$123.41
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.34
ALVOAlvotech Ordinary Shares	C	D	C	$4.95
NVAXNovavax Inc	B	D	C	$9.26
MAZEMaze Therapeutics, Inc. Common Stock	—	—	C	$27.44
SLBTSL Science Holding Limited Ordinary Shares	—	—	C	$2.70
REPLReplimune Group, Inc.	—	—	A	$15.50
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.45
VORVor Biopharma Inc. Common Stock	—	—	B	$22.65
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$21.70
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	B	$13.82
SANASana Biotechnology, Inc. Common Stock	—	—	B	$3.93
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	B	$24.36

About Immunocore Holdings plc American Depositary Shares

Immunocore is a commercial-stage biotechnology company that markets KIMMTRAK for unresectable and metastatic uveal melanoma. The company leverages its proprietary ImmTAX platform to develop a pipeline of candidates across oncology, infectious disease, and autoimmune disorders, including Brenetafusp and other clinical and pre-clinical programs.